For example, glycans can be used as bioreceptors in sensing platforms for the detection of infectious diseases and as cancer biomarkers, including glycolipids such as glycosylphosphatidylinositol (GPI) for the diagnosis of parasites [9,10] and glycoproteins such as the carcinoembryonic antigen (CEA) and the carbohydrate antigen (CA 19-9) as biomarkers for the diagnosis of colon cancer [11,12]. This evidence concerns the gene CEACAM5 and colonic neoplasm.